PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 96 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $104,000 | -38.1% | 90,000 | 0.0% | 0.01% | -33.3% |
Q2 2022 | $168,000 | -66.8% | 90,000 | -46.1% | 0.01% | -55.6% |
Q1 2022 | $506,000 | +48.8% | 167,122 | +85.7% | 0.03% | +107.7% |
Q4 2021 | $340,000 | -26.9% | 90,000 | 0.0% | 0.01% | -27.8% |
Q3 2021 | $465,000 | +34.8% | 90,000 | 0.0% | 0.02% | +50.0% |
Q2 2021 | $345,000 | +49.4% | 90,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $231,000 | +2.7% | 90,000 | 0.0% | 0.01% | +9.1% |
Q4 2020 | $225,000 | +21.0% | 90,000 | 0.0% | 0.01% | -21.4% |
Q3 2020 | $186,000 | -33.3% | 90,000 | 0.0% | 0.01% | -36.4% |
Q2 2020 | $279,000 | -32.0% | 90,000 | -50.0% | 0.02% | -8.3% |
Q1 2020 | $410,000 | +25.8% | 180,000 | +100.0% | 0.02% | -35.1% |
Q4 2019 | $326,000 | -36.3% | 90,000 | -40.1% | 0.04% | -35.1% |
Q3 2019 | $512,000 | -27.5% | 150,257 | 0.0% | 0.06% | -10.9% |
Q2 2019 | $706,000 | +40.4% | 150,257 | 0.0% | 0.06% | +39.1% |
Q1 2019 | $503,000 | +25.8% | 150,257 | 0.0% | 0.05% | +91.7% |
Q4 2018 | $400,000 | – | 150,257 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
CM Management, LLC | 649,400 | $193,521 | 0.20% |
BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |